The Food and Drug Administration posted the notice late Tuesday, warning health professionals that the company has recalled lot H3A7444 of its Cefepime for Injection USP and Dextrose Injection USP. Visible particles were found in a sample from the lot, including specs of metal, cotton fiber and hair.
The agency warned that using the drug could result in blood clots causing stroke, heart attack and other catastrophic problems.
The drug was distributed to hospitals, pharmacies and medical suppliers nationwide, according to the agency's release.
Patients experiencing health problems should contact their physician and report all issues to the company at 1-800-854-6851.
